Nationwide surveillance of drug-resistant tuberculosis in The Netherlands: Rates, risk factors and treatment outcome

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 4, 1998, Pages 288-295

  Lambregts van Weezenbeek, C S B ^a   Jansen, H M ^b   Nagelkerke, N J D ^a   Van Klingeren, B ^c   Veen, J ^a  

^a KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Migration; Resistance; Risk factors; Surveillance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CHEMOTHERAPY; DEMOGRAPHY; DISEASE SURVEILLANCE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MIGRATION; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0031982318     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cohn D L, Bustreo F, Raviglione M C. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/ IUATLD Global Surveillance Project. Clin Infect Dis 1997; 24(Suppl 1): S121-130.
2. Lal Maskay N. Drug resistance of M. tuberculosis and comparison of drug sensitivity test in Nepal. Kekkaku 1993; 68: 97-107.
3. Trivedi S S, Desai S G. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle 1988; 69: 37-42.
4. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
5. Tahaoglu K, Kizkin O, Karagoz T, Tor M, Partal M, Sadoglu T. High initial and acquired drug resistance in pulmonary tuberculosis in Turkey. Tubercle Lung Dis 1994; 75: 324-328.
6. Kim S J, Hong Y P. Drug resistance of Mycobacterium tuberculosis in Korea. Tubercle Lung Dis 1992; 73: 219-224.
7. Danilovitch M, Sillastu H, Kruner A, Türi E. Incidence in tuberculosis and antimicrobial resistance of Mycobacterium tuberculosis in Estonia in 1992-1994. Tubercle Lung Dis 1995; 76(Suppl 2): 100.
8. Miskinis K, Purvaneckiène B. Drug-resistant tuberculosis in Lithuania. Tubercle Lung Dis 1995; 76(Suppl 2): 100.
9. Warburton A R E, Jenkins P A, Waight P A, Watson J M. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991. Commun Dis Rep 1993; 3: R175-R179.
10. Howell F, Kelly P, Clancy L. Pulmonary tuberculosis in the Republic of Ireland: an epidemiological profile from a single unit. Respir Med 1990; 84: 111-117.
11. Gusset T, Rieder H L, Salfinger M. Resistenzhäufigkeit der Tuberkulosebakterien in der Schweiz. Schweiz Rundschau Med 1993; 82(40): 1101-1104.
12. Heldal E. Resistant tuberculosis in Norway 1976-94. Tubercle Lung Dis 1995; 76(Suppl 2): 100.
13. Borchardt J, Kirsten D, Jorres R, Kroeger C, Magnussen H. Drug-resistant tuberculosis in Northern Germany: a retrospective hospital-based study of 1 055 patients from 1984 until 1993. Eur Respir J 1995; 8: 1076-1083.
14. Wanlin M, Fauville-Dufaux M, Pattyn S, Portaels F, Somonet L, Uydebrouck M. Tuberculose : la multirésistance en Belgique en 1992 et 1993. Acta Clin Belg 1996; 53: 150-155.
15. Schneider C, Lasch C, Brade V. Haben Inzidenz und Resistenz der Tuberkulose zugenommen? Epidemiologische Verlaufsbeobachtung anhard kulturell gesicherter Erkrangkungen. Pneumologie 1994; 48: 803-808.
16. Esteban J, Gegundez M I, Garcia-Corbeira P, Soriano F. Incidencia de Mycobacterium tuberculosis resistente a tuberculostaticos: aspectos clinicos e impacto sobre la terapia y evolución. Enferm Infecc Microbiol Clin 1993; 11: 415-419.
17. Fischl M, Uttamchandani R, Reyes R, et al. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. Morb Mortal Wkly Rep 1991; 40: 585-591.
18. Beck-Sagué C, Dooley S W, Hutton M D, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992; 268: 1280-1286.
19. Hoch D E, Wilcox K R Jr. Div. of Tuberculosis Elimination, Centers for Prevention Services, CDC. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility - Michigan. Morb Mortal Wkly Rep 1991; 40: 129-131.
20. Greifinger R, Keehfus C, Grabau J, et al. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. Morb Mortal Wkly Rep 1992; 41: 507-509.
21. Angarano G, Carbonara D, Costa D. Drug resistance of Mycobacterium tuberculosis. Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group. New Microbiol 1995; 18: 69-72.
22. Cotte L, Fougerat F, Trepo C. Nosocomial transmission of multidrug-resistant tuberculosis between AIDS patients (letter). Tubercle Lung Dis 1992; 73: 397-398.
23. Gori A, Franzetti F, Catozzi L, Marchetti G, Moroni M. Peculiar clinical and epidemiological features of tuberculosis in HIV-positive patients. 16th Annual Meeting European Society for Mycobacteriology. Pisa, Italy, June 4-7, 1995. Abstract OP41-71.
24. Vareldzis B P, Grosset J, de Kantor I, et al. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tubercle Lung Dis 1994; 75: 1-7.
25. Van Geuns H A, Hellinga H S, Bleiker M A, Styblo K. Surveillance of diagnostic and treatment measures The Netherlands, 1984. Tuberculosis Surveillance Research Unit of the IUAT Progress Report 1987; Vol.1: 119-155.
26. Lambregts-van Weezenbeek C S B, Van Klingeren B, Veen J. Resistentie bij Mycobacterium tuberculosis in Nederland. Ned Tijdschr Geneeskd 1996; 140(44): 2187-2191.
27. Lambregts-van Weezenbeek C S B, Keizer S T, Sebek M M G G, Schepp-Beelen J C H M, Van der Loo C J. Transmissie van multi-resistente tuberculose in een Nederlands ziekenhuis. Ned Tijdsch Geneeskd 1996; 140(46): 2293-2295.
28. Schaberg T, Gloger G, Reichert B, Mauch H, Lode H. Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. Eur Respir J 1995; 8: 278-284.
29. Long R, Manfreda J, Mendella L, Wolfe J, Parker S, Hershfield E. Antituberculous drug resistance in Manitoba from 1980 to 1989. Can Med Assoc J 1993; 148: 1489-1495.
30. Barnes P F. The influence of epidemiologic factors on drug re- sistance rates in tuberculosis. Am Rev Respir Dis 1987; 136: 325-328.
31. Lambregts-van Weezenbeek C S B, Jansen H M, Veen J, Nagelkerke N J D, van Soolingen D. The origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands; the truth behind the rates. Int J Tuberc Lung Dis 1998; 2: 296-302.